Mineishi S - Search Results

1

Gene therapy utilizing drug resistance genes: a review.

Banerjee D, Zhao SC, Li MX, Schweitzer BI, Mineishi S, Bertino JR. Banerjee D, et al. Among authors: mineishi s. Stem Cells. 1994 Jul;12(4):378-85. doi: 10.1002/stem.5530120404. Stem Cells. 1994. PMID: 7951004 Review.

2

Ex vivo expansion and selection of human CD34+ peripheral blood progenitor cells after introduction of a mutated dihydrofolate reductase cDNA via retroviral gene transfer.

Flasshove M, Banerjee D, Mineishi S, Li MX, Bertino JR, Moore MA. Flasshove M, et al. Among authors: mineishi s. Blood. 1995 Jan 15;85(2):566-74. Blood. 1995. PMID: 7529065 Free article.

3

Long-term protection of recipient mice from lethal doses of methotrexate by marrow infected with a double-copy vector retrovirus containing a mutant dihydrofolate reductase.

Zhao SC, Li MX, Banerjee D, Schweitzer BI, Mineishi S, Gilboa E, Bertino JR. Zhao SC, et al. Among authors: mineishi s. Cancer Gene Ther. 1994 Mar;1(1):27-33. Cancer Gene Ther. 1994. PMID: 7621235

4

Transfection with a cDNA encoding a Ser31 or Ser34 mutant human dihydrofolate reductase into Chinese hamster ovary and mouse marrow progenitor cells confers methotrexate resistance.

Banerjee D, Schweitzer BI, Volkenandt M, Li MX, Waltham M, Mineishi S, Zhao SC, Bertino JR. Banerjee D, et al. Among authors: mineishi s. Gene. 1994 Feb 25;139(2):269-74. doi: 10.1016/0378-1119(94)90768-4. Gene. 1994. PMID: 8112617

5

Development of a retroviral construct containing a human mutated dihydrofolate reductase cDNA for hematopoietic stem cell transduction.

Li MX, Banerjee D, Zhao SC, Schweitzer BI, Mineishi S, Gilboa E, Bertino JR. Li MX, et al. Among authors: mineishi s. Blood. 1994 Jun 1;83(11):3403-8. Blood. 1994. PMID: 8193378 Free article.

6

Post-transplant methotrexate administration leads to improved curability of mice bearing a mammary tumor transplanted with marrow transduced with a mutant human dihydrofolate reductase cDNA.

Zhao SC, Banerjee D, Mineishi S, Bertino JR. Zhao SC, et al. Among authors: mineishi s. Hum Gene Ther. 1997 May 20;8(8):903-9. doi: 10.1089/hum.1997.8.8-903. Hum Gene Ther. 1997. PMID: 9195212

7

Co-expression of the herpes simplex virus thymidine kinase gene potentiates methotrexate resistance conferred by transfer of a mutated dihydrofolate reductase gene.

Mineishi S, Nakahara S, Takebe N, Banerjee D, Zhao SC, Bertino JR. Mineishi S, et al. Gene Ther. 1997 Jun;4(6):570-6. doi: 10.1038/sj.gt.3300439. Gene Ther. 1997. PMID: 9231073

8

Purine salvage rescue by xanthine-guanine phosphoribosyltransferase (XGPRT) potentiates methotrexate resistance conferred by transfer of a mutated dihydrofolate reductase gene.

Mineishi S, Nakahara S, Takebe N, Zhao SC, Banerjee D, Bertino JR. Mineishi S, et al. Cancer Gene Ther. 1998 May-Jun;5(3):144-9. Cancer Gene Ther. 1998. PMID: 9622097

9

Generation of dual resistance to 4-hydroperoxycyclophosphamide and methotrexate by retroviral transfer of the human aldehyde dehydrogenase class 1 gene and a mutated dihydrofolate reductase gene.

Takebe N, Zhao SC, Adhikari D, Mineishi S, Sadelain M, Hilton J, Colvin M, Banerjee D, Bertino JR. Takebe N, et al. Among authors: mineishi s. Mol Ther. 2001 Jan;3(1):88-96. doi: 10.1006/mthe.2000.0236. Mol Ther. 2001. PMID: 11162315 Free article.

10

Active site-directed double mutants of dihydrofolate reductase.

Ercikan-Abali EA, Mineishi S, Tong Y, Nakahara S, Waltham MC, Banerjee D, Chen W, Sadelain M, Bertino JR. Ercikan-Abali EA, et al. Among authors: mineishi s. Cancer Res. 1996 Sep 15;56(18):4142-5. Cancer Res. 1996. PMID: 8797582

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

161 results

Search Page

Filters